FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to a formulation for delivery of amphotericin B and other drugs, wherein the formulation contains an active ingredient, one or more esters of glycerol and fatty acids and one or more esters of fatty acids containing polyoxyethylene oxide, wherein the ratio of esters of glycerol and fatty acids and esters of fatty acids containing polyoxyethylene oxide makes from approximately 20:80 to approximately 80:20 vol/vol.
EFFECT: formulation is applicable for preparing the drug with improved bioavailability for infectious diseases.
13 cl, 21 dwg, 8 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DOSING REGIMENS FOR ECHINOCANDIN CLASS COMPOUNDS | 2013 |
|
RU2719579C2 |
| DOSING MODES FOR ECHINOCANDINE CLASS COMPOUNDS | 2013 |
|
RU2639483C2 |
| PHARMACEUTICAL COMPOSITIONS | 2011 |
|
RU2639482C2 |
| COMPOSITIONS CONTAINING DEUTERATED DOMPERIDONE | 2019 |
|
RU2796537C2 |
| CAPSULES WITH SOLUBLE OESTRADIOL FOR INTRAVAGINAL INTRODUCTION | 2013 |
|
RU2740059C2 |
| IMPROVING ABSORPTION OF THERAPEUTIC AGENTS THROUGH MUCOUS MEMBRANES OR SKIN | 2009 |
|
RU2519193C2 |
| TACROLIMUS FOR IMPROVED TREATMENT OF PATIENTS WITH GRAFTS | 2009 |
|
RU2574006C2 |
| MICROEMULSION COMPOSITIONS INCLUDING SUBSTANCE P ANTAGONISTS | 2005 |
|
RU2397759C2 |
| PHARMACEUTICAL DRUG FORM OF TYROSINE KINASE INHIBITOR FOR PERORAL INTRODUCTION | 2007 |
|
RU2468788C2 |
| SKIN COMPOSITION, INCLUDING VITAMIN D ANALOGUE AND MIXTURE OF SOLVENT AND SURFACE-ACTIVE SUBSTANCES | 2010 |
|
RU2560677C2 |
